. The technological breakthroughs that have revolutionized genomics, proteomics and multiparameter flow cytometry have also provided systems immunologists with a brand new tool kit with which to investigate immunological responses. These advances, along with the studies that have resulted from them, have been discussed elsewhere 6 . In this Innovation article, we focus on the data analysis hurdles encountered by investigators that have adopted systems approaches. Indeed, mining and interpreting large-scale datasets remains the major bottleneck, especially now that profiling technologies have become both robust and fairly inexpensive. Systems-scale data provide detailed phenotypical information and constitute a vast pool of primary data from which key insights can be obtained. Importantly, such data also provide us with the information necessary to map relationships between the individual elements of the immune system and to gain a holistic understanding of the molecular and cellular events that lead to an immune response.
We provide an introduction to network analysis
-an approach that is particularly well suited for the study of interactions between the constituents of a system -and we briefly review the use of this approach for the identification of regulatory networks in immunology studies. We describe the use of network analysis as a means to uncover the relationships that define a biological system, such as the blood, from collections of transcriptome datasets. The resulting repertoire of co-clustering gene sets, also known as modules, can be used as a basis for streamlining data analysis and forging new bioinformatics tools and assays that can contribute towards making systems approaches more widely accessible to the immunology research community.
Network analyses in immunology
Network analyses have been used in immunology to identify the key transcriptional regulators that control the development of immune cells and their response to immunomodulatory factors (for an introduction to network analysis, see BOX 1) . Most studies have relied on co-expression networks constructed from whole-genome transcript profiling to identify candidate regulatory genes that can be subsequently tested in downstream functional screens. The benefit of this approach, compared with more conventional reductionist methods, lies in its ability to accelerate the discovery of 'master regulators' and the assembly of comprehensive regulatory circuits 7 . Network analyses have been most extensively used to unravel the transcriptional networks that control innate immune signalling. These studies are important for elucidating the transcriptional networks that control signalling downstream of the numerous pattern recognition receptors that are expressed by innate immune cells. Recent work has made use of systems-scale and targeted-profiling approaches, together with RNA interference (RNAi) screens, to identify a considerable number of regulators that are involved in Toll-like receptor signalling 8 . In another study, network analyses of systemsscale data and downstream target validation in knockout mouse models identified regulatory nodes that control interferon responses following viral infection 9 . Such work has been well covered by recent reviews 7, 10, 11 and is not discussed further in this article.
Network analyses have also been used in studies to investigate the development of the immune system. The differentiation of haematopoietic stem cell progenitors into various cell populations that are able to carry out a wide range of specialized functions is complex. This process is dictated by anatomical location, by the presence of growth and other immunomodulatory factors and, ultimately, by transcriptional regulation. Investigators studying haematopoiesis have relied on genome-wide transcript profiling technologies for in-depth phenotyping of immune cell populations and marker identification 12 . However, such data have also been used for the construction of large co-expression networks [13] [14] [15] [16] . One of the most comprehensive networks that has been built to date was constructed using transcriptional profiles from 38 purified cell populations, including haematopoietic stem cells, progenitor cells and cell populations at multiple stages of maturation 15 . This study identified modules of tightly co-expressed genes, inferred regulatory circuits controlling haematopoiesis and then screened candidate master regulators in downstream binding and functional assays. More recently a similar endeavour led to the identification of the factors that regulate haematopoiesis in mice 16 . In another study, a regulatory network incorporating microRNA (miRNA) and Abstract | Individual elements that constitute the immune system have been characterized over the few past decades, mostly through reductionist approaches. The introduction of large-scale profiling platforms has more recently facilitated the assessment of these elements on a global scale. However, the analysis and the interpretation of such large-scale datasets remains a challenge and a barrier for the wider adoption of systems approaches in immunological and clinical studies. In this Innovation article, we describe an analytical strategy that relies on the a priori determination of co-dependent gene sets for a given biological system. Such modular transcriptional repertoires can in turn be used to simplify the analysis and the interpretation of large-scale datasets, and to design targeted immune fingerprinting assays and web applications that will further facilitate the dissemination of systems approaches in immunology.
transcript profiling data, that had been obtained in nine blood leukocyte populations, identified a small number of cellspecific mi RNAs that are likely to have a role in haematopoietic cell development and functional specialization 17 . The intricate cellular and molecular events that take place during the development of immune responses have also been investigated using systems-scale profiling approaches. Immune responses involve the terminal differentiation of cells of the adaptive immune system into highly specialized effector cells. The differentiation of B cells into antibody-secreting cells and memory B cells is controlled by several key regulators 18 . Transcription factors that promote the B cell gene expression programme are essential for B cell development and maturation (for example, paired box protein 5 (PAX5) and BTB and CNC homologue 2 (BACH2)), for the formation of germinal centres (for example, B cell lymphoma 6 (BCL-6), octamer-binding transcription factors (OCTs) and OBF1 (also known as POU2AF1)) and for modulating the cell differentiation process. Another set of regulators promotes the antibody-secreting cell gene-expression programme (for example, interferon-regulatory factor 4 (IRF4) and B lymphocyte-induced maturation protein 1 (BLIMP1; also known as PRDM1)). Transcriptome profiles of B cell populations at different stages of their development have been generated 1, 19, 20 , but an extensive analysis of the transcriptional networks that regulate B cell differentiation is yet to be undertaken.
T cells also undergo cellular changes as they develop from antigen-inexperienced naive cells into specialized effector cells that have acquired, for example, regulatory, memory or exhausted phenotypes. These multiple differentiation pathways are regulated at the transcriptional level, and several master regulators of T cell fate have been identified through reductionist candidatebased approaches. Examples of these master regulators include transcription factors such as T-bet, GATA-binding protein 3 (GATA3), retinoic acid-related orphan receptor-γt (RORγt) and forkhead box P3 (FOXP3), which have been implicated in the development of CD4 + T cells into various T helper or regulatory T cell subsets. More recent efforts have used large-scale profiling platforms to obtain in-depth molecular phenotypes of various T cell subsets and have identified a plethora of new candidates to be tested [21] [22] [23] [24] [25] . Such a systems approach has, for example, led to the characterization of the transcriptional programme that is upregulated by programmed cell death protein 1 (PD1) in exhausted CD8
+ T cells and uncovered the role of the transcription factor basic leucine zipper transcriptional factor ATFlike (BATF) in this process 26 . In another recent study, investigators identified 39 candidate regulators of mouse T helper 17 (T H 17) cell differentiation through the investigation of the dynamic regulatory networks that are derived from temporal transcriptome profiling data 27 . Remarkable progress in our understanding of the molecular mechanisms that regulate immunity has been achieved through systems-scale network analyses. However, it is evident that more work is needed, especially to uncover the transcription factors involved in regulating lymphocyte differentiation and to identify the transcriptional circuits that these factors regulate 28 .
Modular repertoire analysis
Network analyses have been pioneered and expertly applied to the mining of systems data by several groups with the main goal of unravelling the key elements that regulate transcriptional programmes (as shown above and in . However, network analyses have not been adopted as a mainstream approach for the analysis of large-scale data. Instead, most investigators have favoured other strategies that often involve feature selection (group comparison) or dimension reduction (for example, hierarchical and k-means clustering principal component analysis)
. These dimension reduction approaches are easier
Box 1 | A basic introduction to network analysis
The availability of large-scale profiling technologies provides a unique opportunity to study relationships among the elements of a given system. These relationships can be visualized as a network or a graph, in which nodes represent elements of the system (for example, genes, transcripts, proteins or metabolites) and edges represent the relationship between any two elements (for example, functional, physical or regulatory elements) 49 . Edges may be undirected to indicate a symmetrical relationship (that is, the relationships from A to B and from B to A are equivalent) as occurs in co-expression and physical interaction networks, or they may be directed (that is, a relationship from A to B implies nothing about a relationship from B to A) as often occurs in regulatory and enzymatic networks. Edges can also be weighted either quantitatively or qualitatively to indicate the relationship type or strength (see the figure) .
Analysing networks of the scale dictated by systems biology approaches is challenging. Unfortunately, using the majority of available layout algorithms, large networks have a tendency to form the infamous 'hairball', which can be impressive visually, but is of limited value for data interpretation. Not only are such visualizations too cluttered for the human eye to easily distinguish structural features, particularly given our propensity for finding meaningful patterns in meaningless or random data, but also most layout algorithms are stochastic and produce multiple layouts for a single network. In addition, such layouts are typically not robust and can change markedly with only minor alterations to the underlying data. For these reasons and others, it is difficult to visually compare and to contrast networks even when the visualization is generated by the same layout algorithm. Recent work in graph visualization addresses problems of reproducibility and comparability (Hive Plots 50 and Circos
51
) but the fact remains that systematic analysis of large-scale network data is still better accomplished through objective computational approaches.
CSF2, colony-stimulating factor 2; JAK, Janus kinase; IL, interleukin; IL2RG, interleukin-2 receptor γ-chain; IL4R, interleukin-4 receptor; IL13RA1, interleukin-13 receptor α1; k 1 , rate of enzyme-substrate association; k 2 , rate of enzyme-substrate dissociation; k cat , rate of enzyme catalysis; STAT6, signal transducer and activator of transcription 6. 
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to implement and are effective methods for reducing dimensions because they group genes or samples on the basis of similarities in patterns of gene expression, which is an essential step for the interpretation of large-scale data. They also facilitate the visualization of data through clustering on a heat map or through principal component analysis (PCA) plots, which can be valuable sources of insight. Conversely, network analyses are more computationally intensive approaches and limited information is conveyed through the visualization of large networks. It should be noted that functional networks, which are ubiquitously used to assist with the interpretation of analysis results, are not built on the basis of largescale data but are derived from curated knowledge bases.
In our work, we have used network analyses to identify variable dependency, and have taken advantage of this information to simplify mainstream analysis and the interpretation of large-scale data. This approach is statistically valuable. When carrying out t-tests on tens of thousands of variables, which require stringent multiple testing corrections in order to control falsepositive rates, one assumes that all variables are independent of one another. However, this is not the case in biological systems. For example, when analysing tissues such as the blood, the expression of numerous transcripts will change in a co ordinated manner as a result of the induction of antiviral or inflammatory pathways, or as a result of the presence or absence of certain leukocyte populations. Network analyses can be used a priori to determine interdependence between variables of a biological system of interest -for the blood transcriptome. In this case, we have used a collection of blood transcriptome datasets obtained from patients with a wide range of immunological conditions as an input to identify the repertoire of possible co ordinated transcriptional perturbations that can be measured in this tissue. This led to the identification of sets of interdependent transcripts, known as modules, which can be used as a framework for the subsequent analysis and interpretation of blood transcriptome datasets.
Modular repertoire identification
Human whole blood is used as an example in this section to show how modular repertoires can be established for a given biological system. Blood is an accessible tissue and a valuable source of information in human immunology studies. Blood transcript profiling has been used for more than 10 years to identify perturbations that are associated with disease pathogenesis, which has led to the identification of novel therapeutic targets and to the development of biomarker signatures 33, 34 . This systems approach has more recently been used to investigate immune responses in vivo following the administration of vaccines [35] [36] [37] [38] [39] . A basic introduction to modular repertoire identification is provided here to provide an understanding of the basic principles that underpin this approach (a complete description of the method is available in REF. 40 ).
Construction of the co-clustering network.
The first step involves assembling a collection of transcriptome datasets (FIG. 1) . As our specific interest is in surveying changes in transcript abundance in blood that are associated with disease pathogenesis, we used blood profiles generated from patients with a wide range of diseases. Each disease-associated dataset corresponds to a specific disease, includes cases and appropriate controls, and is generated as a single batch using the same microarray platform. So far we have used between eight and 15 carefully curated datasets for repertoire identification, including a wide range of autoimmune, infectious and other immune-mediated diseases, and encompassing nearly 1,000 whole transcriptome profiles. Transcripts in each dataset are clustered according to similarity in pattern of expression across all samples in that particular dataset. The results are used as an input to build a co-clustering network. In this network, edges are drawn when two transcripts (nodes) cluster together (co-clustering) in at least one dataset. Edges are weighted according to the number of times a pair of transcripts co-cluster (for example, they might co-cluster in all input datasets or they might co-cluster in all but one input dataset, and so on). This can be compared to a social network connecting genes that tend to 'hang out' , as determined by their clustering behaviours in different situations. Some genes may always be found together and co-cluster 100% of the time, whereas others may never end up in the same clusters in any of the datasets.
Box 2 | Mainstream analytical approaches in systems studies
This box provides a high-level overview of the analytical approaches that are commonly used in systems studies. They are grouped in three main categories.
Feature selection
These approaches aim to identify, for a given dataset, a subset of features (for example, transcripts) that are meaningful or informative. These are signatures (that is, subsets of analytes detected by a given assay) that differentiate study groups, or that correlate with other analytes or study parameters of interest. Feature selection relies on arbitrary cut-offs that may be statistical (p values) or otherwise (for example, fold change). An alternative to the use of cut-offs is the rank ordering of analytes (for example, on the basis of fold change, r values, p values or other parameters). The large number of measurements derived from systems approaches requires the analyst to pay particular attention to false positives that result from multiple testing. Statistical testing has an important role in identifying subsets of features but one should also take the biological importance or meaning into account when carrying out such analyses. The investigator may rely on their knowledge of the biomedical literature to infer biological importance, on annotations or, in the case of module repertoire analyses, on co-clustering information obtained at the systems level.
Dimension reduction
Dimension reduction is another cornerstone of systems-scale analyses that is used for scaling down the data to a manageable number of variables. When using a data-driven approach it generally consists of the identification of co-variates that are collapsed into new composite variables (for example, principal component analysis) or grouped together as a set or signature (for example, hierarchical clustering or k-means clustering). When using a knowledge-driven approach variables can also be grouped on the basis of similarity in function or on participation in a molecular pathway. However, a known functional association does not necessarily result in correlated measurements and it is therefore usually not possible to derive summarized data from such functional gene sets or modules.
Functional interpretation
Functional interpretation can be guided by the use of bioinformatic tools but should rely on the investigator's own judgement and insight. Bioinformatic tools can bring context, can provide the analyst with an initial direction and can rely on testing for enrichment of a given set of analytes across 'canonical' functional sets corresponding to pathways or ontologies. When basing interpretations on the results of such analyses, one should be aware of the fact that it tends to reinforce well-established knowledge and therefore present some degree of circularity.
Identification of the modular repertoire. The next step consists of identifying and extracting sub-networks (known as modules) from this large and intricate co-clustering network. The identification of groups of highly interconnected gene sets is achieved by approaching the network as a mathematical structure or graph, using methods that have been developed by a field of mathematics and computer science called graph theory
. Our algorithm starts by identifying the sub-network with the most connected genes that co-cluster in all input datasets. It then 'pulls in' additional genes that connect with this core network but that co-cluster less frequently (all but one, two, three, and so on). In the next round of selection the level of stringency that is used to identify core networks is progressively relaxed to identify modules formed by genes that co-cluster in all but one, two, three or more datasets. In the last round of selection modules are constituted by sets of transcripts that co-cluster in only one dataset.
Thus, this step-wise approach effectively captures relationships between constitutive elements of a given biological system (for example, the blood) and a given range of perturbations (for example, diseases). Transcripts that co-cluster in most diseases will constitute modules that are selected early on in the process. Transcripts that co-cluster more specifically will constitute modules that are selected in later rounds of selection. In our example, nine input datasets were used from diverse disease states including infection, autoimmunity, immune deficiency and transplantation. As a result, 260 modules were identified, which comprise more than 14,000 transcripts 36, 41 .
Functional interpretation of the modular repertoire. The next step consists of functionally characterizing this modular transcriptional repertoire. As in any other tissue, changes in transcript abundance in the blood can be attributed to transcriptional regulation as well as to relative changes in cellular composition, which will be reflected in the modular transcriptional repertoire of whole blood. This fact is especially important to keep in mind when analysing such data, and strategies may be used to attempt to tease apart changes that can occur as a consequence of these factors. Transcriptional profiles that have been obtained for isolated cell populations may be used to aid with data interpretation 37 . Statistical deconvolution strategies that have been devised for differential gene expression analysis in individual cell types in a biological sample 42 could also be implemented using summarized module-level data as an input.
One of the premises of module repertoire analysis is that co-clustering among gene sets is driven by biological phenomena. Thus, a great deal of time and effort can be dedicated to the interpretation of modular frameworks that are used in the Nature Reviews | Immunology Figure 1 | Modular repertoire identification. Modular repertoires are determined for a given biological system, such as whole blood, through an entirely data-driven process. A collection of relevant transcriptome datasets is assembled and carefully curated using quality control criteria. Each dataset is independently clustered and co-clustering events are recorded. This information is used to build a large co-clustering network. Each edge that connects two genes indicates a co-clustering event. Edges carry different weights depending on the number of datasets in which two genes co-cluster. Highly connected sub-networks (modules) are mined using graph theory. The first round of selection (the M1 modules) selects sub-networks for which connections carry the maximum weight (that is, genes co-cluster in all datasets). Subsequent rounds of selection (the M2, M3, M4 modules, and so on) facilitate the selection of modules for which genes co-cluster in all but one, two, three or more datasets. Finally, the resulting collection of modules is subjected to functional interpretation. analysis of datasets over a span of several years. A wide range of approaches can be used to derive functional annotation for gene sets. We used several commercially and publically available tools that rely on term enrichment to give an indication of the functional annotations that may be associated with each module gene list. However, contextualization should ultimately rely on the knowledge and the intuition of the investigators who are assisted by such bioinformatic tools. As a degree of subjectivity is inherent to functional interpretation, we have created a Wiki site (G2 Trial 8 Modules) that can gather data inputs from a large user community and which can function as a reference.
Dataset analyses
Modular repertoires are identified using transcriptome profiles derived from a large number of samples and a wide range of conditions. Modifying the type of sample (for example, peripheral blood mononuclear cells (PBMCs) instead of whole blood), the input datasets or the microarray platform used has a limited effect on repertoire identification, especially with regard to the modules that are identified early on in the selection process when transcripts co-clustering in all or in the majority of input datasets are selected.
We have shown that the use of coordinately expressed gene sets (modules) improves robustness when comparing results across platforms and across studies 43, 44 . Hence, the modular repertoire identified in the example provided is well suited for use as a generic framework for the analysis and interpretation of blood transcriptome datasets. The work that has been published so far by our laboratory has used only two modular repertoire frameworks for blood transcriptome analysis: the first uses PBMC samples run on the Affymetrix platform 40 and the second uses whole blood samples run on Illumina 36 . A key difference between the modular repertoires and gene sets derived from knowledge-driven approaches or differential expression analyses stems from the fact that modular repertoires consist of sets of coordinately expressed genes. In addition, as these transcripts follow similar patterns of expression in the tissue of interest (for example, whole blood) values can be summarized at the module level. This summary can be simply calculated by averaging the normalized expression values of all of the genes that constitute a module. It is also possible to determine the proportion of transcripts that pass a statistical filter for a given module, and the categories 'increased' , 'decreased' or 'unchanged' are used to assign activity scores for each module on the basis of the percentage of increased versus decreased transcripts. Alternatively, one can simply calculate the proportion of transcripts that are increased compared with decreased without applying any statistical filter. In this case, in the absence of changes, the proportion of genes that show increases compared with decreases will be close to a ratio of 50/50. When changes occur, a skewing of this ratio will be observed. This approach can detect small but coordinated changes in transcript abundance that would not be considered to be significant when treating genes as independent variables.
Working at the module level using summarized expression values also presents a distinct advantage when it comes to visualizing results (FIG. 2) . Changes in transcript abundance can be represented as easily interpretable 'fingerprints' using a grid against which modules from different rounds of selection are aligned. The position on the grid denotes the order of module selection. One row is used for each round of selection, with the first row corresponding to modules composed of the transcripts co-clustering in all input datasets (first round: M1), the second row corresponding to modules composed of the transcripts co-clustering in all but one dataset (second round: M2), and so on. Columns indicate the sequence of selection within each round; for example, module M3.4 was the fourth module identified (fourth column) within the third round of selection (third row).
The transcripts that show significantly increased abundance relative to a baseline value (calculated, for example, from healthy controls) are represented by a red spot. A significant decrease in transcript abundance is indicated by a blue spot. A colourcoded key indicates the predetermined functional annotations for each module represented on the grid. With a little practice, a trained eye can functionally interpret the results by taking a rapid glance at the transcriptional perturbations represented in a fingerprint format. We have developed web applications that can be used to explore modular fingerprints, which provide users with the opportunity to change cut-off values and to access gene level data and interpretations. For this Innovation article, we provide an interactive version of FIG. 2 that was generated for whole blood transcriptional profiles derived from a cohort of children infected with Staphylococcus aureus 41 . An interactive version of Figure Cross-sample analyses As described in the section above, group comparisons carried out at the gene level or module level select genes with differences in transcript abundance that are consistent
Box 3 | Mining networks with graph theory
When analysing networks, there are questions that are common to most fields of research. How does network A compare and contrast with network B? How robust is the network? Which nodes are 'critical' to the network? Which nodes affect (or are connected to) the largest number of other nodes? The field of graph theory, which is a subfield of discrete mathematics, concerns the study of such graphs and is used to answer questions such as these. Once a problem has been abstracted to a corresponding graph, much can be learned about the underlying characteristics and structure using graph theoretical methods. Often this can help to explain real-world observations.
As an example, biological data tends to produce scale-free, small-world networks 52 . Scale-free networks are characterized by nodes, the degree distribution of which asymptotically follows a power law distribution. Put simply, these networks have relatively few, very highly connected nodes (referred to as hubs). Small-world networks are those in which most pairs of nodes are not connected to one another but most nodes can be reached from every other node through a small number of connections. One of the properties of this type of network is a high tolerance for random node failure 53 . Information flowing through the connections of the graph is not interrupted until a fairly large number of random nodes are deleted because an individual node is rarely necessary to preserve connections between other pairs of nodes. This characteristic is clearly exemplified by the robustness of biological organisms to genetic knockouts. In this example, a node (that is, a gene and its products) has been removed from the network (the interactome) and other nodes functionally compensate for the deletion. This feature has obvious implications when attempting to identify 'critical' nodes, whether as potential drug targets, genetic knockouts or as vaccination targets to inhibit the spread of disease. By contrast, the random approach is unlikely to yield effective results.
between study groups (for example, case studies versus controls). But this approach tends to mask potentially informative signatures that show variability across a study population. It can be important to identify and characterize the molecular heterogeneity found in a given dataset. A modular framework can be used to assess the changes in transcript abundance in individual study subjects using a control group (for example, healthy individuals) as a baseline. First, the proportion of transcripts that deviate from the healthy group is recorded (using a cutoff value that is based on fold change and/or standard deviation). As detailed above when carrying out group comparisons, the resulting values are the percentage of genes for which transcript abundance increases, decreases or does not change, this is determined for each individual subject for cross-sample analyses. Thus, it is possible to map changes in transcript abundance on a fingerprint grid (FIG. 2) , but this time for an individual subject rather than for a group of subjects. In order to investigate the patterns of transcript abundance among individuals, a heat map format can be used where samples (the columns) and modules (the rows) are ordered on the basis of similarities via hierarchical clustering (FIG. 3) . This analytical strategy was used for the molecular stratification of the paediatric patient cohort used in our example 41 . An interactive version of Figure 3 is available online. For a full explanation of this and other interactive figures see Supplementary Information and BOX 2.
Disease classification that mostly relies on the observation of clinical symptoms may not reflect the underlying molecular and immunological events that lead to pathogenesis. Hence, there is often a need for complementary molecular approaches to classify disease, which may lead to the improved selection of treatment modalities. Thus, investigating perturbations of transcriptome repertoires in individual subjects provides a means to assess the immunological changes that are associated with pathogenesis, disease progression or response to treatment.
Cross-study analyses
The interpretation of results of systemsscale investigations can be taken further when the context is provided by data in the public domain. Vast amounts of data are available in public repositories such as the Gene Expression Omnibus from the National Center for Biotechnology Information. However, carrying out analyses across studies presents a challenge because of variations in sample collection and processing methodologies, and because of the use of different microarray or sequencing platforms. We have found that changes in transcript abundance when summarized at the module level showed a high level of concordance across platforms 43 . Indeed, as the genes that constitute each module in the biological system of interest are co-dependent, the effect of differences in probe design or mapping across platforms on overall module activity is minimized. In addition, control groups can be used as common denominators and normalizing factors for the comparison of results of modular repertoire analyses from several independent studies. Thus, pre-existing reference data can be used for the interpretation and external validation of results that have been obtained by analysing a new dataset. Furthermore, collections of public datasets can also be subjected to large-scale meta-analyses for de novo discovery (FIG. 4) .
As an example, the modular transcriptional signatures of patients infected with S. aureus (that are used in the examples provided above) are compared with signatures that have been generated from eight reference datasets, including a validation cohort, as well as datasets that were generated in the context of other studies of acute viral infection (for example, human rhinovirus (HRV), influenza virus and respiratory syncytial virus (RSV)), tuberculosis and septicaemic melioidosis (FIG. 4) ( REFs 33, 45, 46, 47) . An interactive version of Figure 4 is available online. For a full explanation of this and other interactive figures see Supplementary Information and BOX 2. Thus, the development of approaches that facilitate the extraction of knowledge from the vast body of data accumulating in public repositories has become crucially important, and the use of modular repertoire frameworks may help with this daunting task.
Transcriptome fingerprinting tools
Immunologists increasingly rely on systems approaches to gain a global perspective on the intricate molecular and cellular events that are involved in the control of immune responses. However, access to systems profiling technology and the bioinformatics expertise necessary to implement systems immunology studies can prove prohibitive for their mainstream use. As shown in the examples provided above, modular repertoires can provide a simplified analytical framework that is accessible to a wide range of users. Modular repertoires can also function as a basis for the development of streamlined and cost-effective assays that can be substituted for genome-wide screens in biomarker discovery and in immune phenotyping or monitoring (FIG. 5) . Given that each module consists of a set of co-clustered genes, we can select from each module a subset that best represents the changes in transcript abundance observed M6 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) for the overall set. The assay can be scaled by adjusting the number of modules covered and the number of surrogate targets selected per module; for example, a 160 gene assay would cover 40 modules with four surrogate genes per module. The construction of a modular repertoire and the subsequent selection of surrogate genes within each module is entirely data driven and unsupervised (that is, not informed by knowledge of group labels). In addition, the resulting 'transcriptome fingerprinting' assays can measure transcript abundance of hundreds, rather than tens of thousands, of genes while still reflecting changes that occur at the global level. Indeed, the full complement of genes that the selected surrogate transcripts represent remains available for functional interpretations of the changes that are observed using a fingerprinting assay. Carrying out assays using a targeted set of genes has several advantages over genome-wide screens. Notably, it can be Nature Reviews | Immunology carried out using so called 'meso-scale' profiling technologies, such as highthroughput PCR, direct RNA capture and counting, or targeted RNA sequencing. These technologies are highly sensitive and have a wide range of applications. The reagent cost per sample is also reduced (approximately US$25 to US$50 per sample for a custom 200 gene panel), as is the personnel time that is required for sample processing and data analysis. Such an assay can be implemented in a given study with minimal technology or bioinformatic infrastructure and with a rapid turnaround. It can function as an exploratory platform for biomarker discovery or immune profiling. The repertoire that these assays are built on uses a predetermined collection of input datasets. Although a wide range of changes in transcript abundance that are associated with pathogenesis and immunity will be captured by this assay, it cannot replace a truly unbiased systems-scale screen and thus some signatures may be missed. That said, the limited number of preselected variables that is used in a targeted assay can also increase the chances of picking up significant differences as p-value corrections for multiple testing will be less penalizing when measurements are made for hundreds rather than tens of thousands of variables. Transcriptome fingerprinting may also be a suitable first step for screening large collections of samples to inform the design of subsequent whole transcriptome studies (for example, the results could be used to make a 'go' or a 'no go' decision with regards to a future study, and to determine sample sizes and select appropriate time points for studies that are carried out).
Conclusions
The establishment of stable modular repertoires could constitute a new paradigm for the analysis of systems-scale data. The first step consists of mining large collections of relevant datasets using powerful, but relatively complex, network analysis. However, once this repertoire has been determined investigators can use it as a simplified framework for the analysis and interpretation of their own data. Using sets of coordinately expressed transcripts also introduces some degree of redundancy, adding robustness to results and enabling analyses across datasets or platforms. Limitations include the choice of input datasets for construction of the modules, which may not be optimal for all subsequent datasets analysed. However, using diverse dataset inputs is likely to generate modules that are relevant across most diseases in early rounds of module selection, as well as modules that reflect more disease-specific pathways in later rounds of selection. The construction of modular repertoire libraries should contribute to the more widespread adoption of this analytical approach. Since its initial publication in 2008, our modular repertoire framework has been updated only twice, with the third generation of modules to be released soon (D.C., N.B. and M. C. Altman, unpublished observations), but others have started to contribute additional repertoires and we anticipate that more will be released in the future 48 . The emergence of new technology platforms, methodological improvements and an ever-growing pool of available data are the main factors driving the generation of new modular repertoires. Early testing indicates that the current framework that has been built using array data works well when analysing RNA sequencing (RNA-seq) data, but future work will require modular repertoires to be built from large collections of RNA-seq data. It is also important to keep in mind that modular repertoires are system-specific and, although the approach may be broadly applicable, it has so far only been successfully applied to blood profiling. Importantly, the development of custom web applications and targeted fingerprinting assays should help with the dissemination of systems or systems-based approaches to the wider immunology research community 36 . 
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Figure 5 | Transcriptome fingerprinting assays. Modular repertoires can be used as a basis for the development of targeted assays. Transcripts within a module that best represent the overall pattern of transcriptional activity are used as surrogates for the entire gene set. This facilitates the profiling of transcriptome repertoires with a combined set of representative targets using a cost-effective and sensitive 'meso-scale' profiling assay (interrogating tens or hundreds of transcripts). ABCC3, ATP-binding cassette, sub-family C; ABLIM3, actin binding LIM protein family, member 3; ACRBP, acrosin-binding protein; ACSBG1, acyl-CoA synthetase bubblegum family member 1; HT PCR, high-throughput PCR; ID, identifier.
